FDA.reportPublic FDA data

4 ML bevacizumab-nwgd 25 MG/ML Injection [Jobevne]

RxCUI
2712055
RxNorm name
4 ML bevacizumab-nwgd 25 MG/ML Injection [Jobevne]
Display name
4 ML bevacizumab-nwgd 25 MG/ML Injection [Jobevne]
Full name
4 ML bevacizumab-nwgd 25 MG/ML Injection [Jobevne]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:03

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761175Jobevnebevacizumab-nwgd351(k) BiosimilarRx2026-07-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
JOBEVNEBEVACIZUMAB-NWGDBiocon Biologics Inc.70ab1de6-fb68-aee4-a6cb-f9a0f146687f2026-03-11Warnings, Adverse reactionsExact identifier
rxcui: 2712055

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
70ab1de6-fb68-aee4-a6cb-f9a0f146687fJobevne 100 MG in 4 ML Injection [PSN] · 4 ML bevacizumab-nwgd 25 MG/ML Injection [Jobevne] [SBD] · Jobevne 100 MG per 4 ML Injection [SY]34These highlights do not include all the information needed to use JOBEVNE safely and effectively. See full prescribing information for JOBEVNE . JOBEVNE ™ (bevacizumab-nwgd) injection, for intravenous use Initial U.S. Approval: 2025 JOBEVNE (bevacizumab-nwgd) is biosimilar* to AVASTIN ® (bevacizumab)20250401